Taurine — The Sunlight Experiment

What Is Taurine?

Taurine is a sulphur-containing, conditionally essential amino acid found at high concentrations in heart, muscle, and brain tissue. Unlike most amino acids it is not incorporated into proteins; instead it plays roles in bile-salt conjugation, osmoregulation, calcium handling, and membrane stabilisation. It is taken as a supplement (and added to energy drinks) for cardiovascular support, exercise performance, and a subjectively “calming” effect. The cardiovascular and metabolic literature is the strongest part of its evidence base, though many trials are small.

Evidence

The best-studied area is cardiovascular function. An early double-blind crossover trial reported that taurine improved New York Heart Association functional class in patients with congestive heart failure ^{1Reference 1Azuma J et al. · 1985RCTTherapeutic effect of taurine in congestive heart failure: a double-blind crossover trial — randomised crossover trialView study →}, and a later randomised placebo-controlled trial found improved exercise capacity in heart-failure patients supplemented with taurine ^{2Reference 2Beyranvand MR et al. · 2011RCTEffect of taurine supplementation on exercise capacity of patients with heart failure — randomised controlled trialView study →}. A 2024 systematic review and meta-analysis of randomised controlled trials concluded that taurine was associated with favourable effects on blood pressure, heart rate, and left-ventricular ejection fraction, while noting that many contributing trials were small ^{3Reference 3Guan L et al. · 2024Meta-analysisInsights into the cardiovascular benefits of taurine: a systematic review and meta-analysis — meta-analysis. https://pubmed.ncbi.nlm.nih.gov/39148075/View study →}. Popular claims around “calm,” focus, and general energy-drink benefits are widely made but were not backed by a citable, verified trial in this quick pass; those should be treated as unproven pending a full review.

Dosage & Safety

Doses studied in cardiovascular trials were commonly around 1.5 g/day (e.g., 500 mg three times daily) ^{1Reference 1Azuma J et al. · 1985RCTTherapeutic effect of taurine in congestive heart failure: a double-blind crossover trial — randomised crossover trialView study →}^{2Reference 2Beyranvand MR et al. · 2011RCTEffect of taurine supplementation on exercise capacity of patients with heart failure — randomised controlled trialView study →}, and supplement products often use 500 mg–3 g/day; these ranges are informational and not a personal recommendation. Taurine was generally well tolerated in the cited trials, and its toxicity appears low, but formal upper-limit, drug-interaction, and pregnancy/lactation safety data were not established or fully assessed in this pass. People with heart failure or other cardiac conditions should not self-treat and should involve a clinician.

References

Azuma J, et al. (1985). Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial — randomised crossover trial. Clin Cardiol. https://pubmed.ncbi.nlm.nih.gov/3888464/
Beyranvand MR, et al. (2011). Effect of taurine supplementation on exercise capacity of patients with heart failure — randomised controlled trial. J Cardiol. https://pubmed.ncbi.nlm.nih.gov/21334852/
Guan L, et al. (2024). Insights into the cardiovascular benefits of taurine: a systematic review and meta-analysis — meta-analysis. https://pubmed.ncbi.nlm.nih.gov/39148075/